Navigation Links
Evolution of human genome's 'guardian' gives people unique protections from DNA damage
Date:1/16/2008

chromosomes that help shield against damage. Shorter telomeres can make people more susceptible to chromosomal damage and increase our risk of developing malignant tumors. When genes replicate, the process does not copy the very ends of the gene, so telomeres act like caps on the ends of shoelaces, helping preserve DNA structure and preventing genetic unraveling and loss of genetic information.

A clue to p53 functional differences may be found in sunlight. Exposure to the ultra-violet rays in sunlight activates the DNA-damage responses of the repair gene (Ddb2) in humans, but the same gene does not function in rodents. Some studies have suggested that rodents may have a reduced need for genetic protection from sunlight because they are nocturnal and have a fur shield.

Although the full implications of these evolutionary points remain far from clear, our work demonstrates that there has been both refinement and evolution of gene networks controlled by p53, Dr. Aronow said. Exciting work is underway by research groups within the National Cancer Institutes Mouse Models of Human Cancer Consortium to develop mice that are genetically engineered to test the combined effects of altering p53 and telomerase, the enzyme that controls the length and stability of repeating DNA sequences in the telomere region. Mouse models will continue to become progressively more powerful tools for studying human cancer and additional information about the p53 network will help us refine our interpretation of pre-clinical research that may lead to improved cancer prevention for at-risk and normal individuals.

In conducting their analysis of p53 target genes, the international research team used comparative DNA sequence analysis and functional tests of highly engineered yeast and mouse cell culture assays to examine 47 established p53 response elements in 14 vertebrate and non-vertebrate species. The study included researchers from the National Institute for Cance
'/>"/>

Contact: Nick Miller
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Local Oncology Group Leads Online Effort to Revolutionize Cancer Care
2. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
3. VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches Resolutions 2.0
4. UCLA Program Aims to Revolutionize Kidney Transplants
5. Prescription for an electronic revolution?
6. Adapting to pregnancy played key role in human evolution, study shows
7. Evolution Tips the Balance in Moms Favor
8. Informed Medical Communications Sells Consumer Internet Division to Revolution Health
9. Chinas Anti-Aging Revolution
10. New Low-Impact Cosmetic Surgery Treatments Revolutionizing Industry
11. ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...archers at the University of Michigan Comprehensiv...t indicate which patients are more likely to survi... , Most notably, they found that cancers linked ...onsive to current chemotherapy and radiation treat...certain growth factor receptor are the least respo...
(Date:5/12/2008)...12 /PRNewswire/ -- Keck Graduate Institute (KGI),t... ceremony will feature,the graduation of KGI,s fir... and the unveiling of KGI,s first donated artwork....ement in becoming the,first graduate of our new Ph...ce president for academic affairs, dean of faculty...
(Date:5/12/2008)...NASDAQ: CRME TSX: COM, VANCOUVER, May 12 /PRNewsw...ME / TSX: COM) today announced that it will report...n the afternoon of Tuesday, May 13,2008. Cardiome...30pm,Eastern (1:30pm Pacific) on that day to discu...lease dial 416-641-6117 or,866-299-6655. There wil...
(Date:5/12/2008)...t Featuring Synchronized Slides at 5pm Today, LAW...tage Medical, Inc.,(Nasdaq: NXTM ), a leading man...nnounced its financial results for the first quart...quarter of 2008 were $31.0 million, compared to,$8...million in the fourth,quarter of 2007. Revenues in...
Breaking Medicine News(10 mins):Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 2Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 3Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11
...etables in your daily diet may lower the risk of d...e findings are important because the number of dis...nd 2050. Obesity, lack of physical exercise, alcoh...le risk factors for disability, but little is know...
... say the arthritis drug rofecoxib (Vioxx) is found...dy researchers looked at health records of about 1... attack when the research started. About 70 percen...idal anti-inflammatory drug (NSAID). Compared to t...
... suggest stroke survivors who stop taking their pr...ely to have another stroke within the month. Resea...schemic attack (TIA) patients who were on long-ter...ent strokes or heart attacks. TIA is a transient s...
...en who suffer migraines with vision loss have a 70...omen who do not have a history of migraines. In th... of whom had suffered strokes. They investigated w...graines with visual lines and spots increased the ...
Other Medicine News:
(Date:5/9/2008)...Ardea Biosciences, Inc.,(Nasdaq: RDEA ), a compan...l- molecule therapeutics for the treatment of HIV,... today announced that John W. Beck,has been appoin...and Chief,Financial Officer effective May 27, 2008...ly thereafter. The Company also reported recent,ac...
(Date:5/9/2008)...ositive Results with X-ray ... -- Roche today announced one-year,results from a ...TM),(tocilizumab) can significantly inhibit progre...ith rheumatoid arthritis (RA), a critical measure ...o demonstrated that ACTEMRA,reduces disease signs ...
(Date:5/8/2008)...DATATRAK International, Inc.,(Nasdaq: DATA ), a t...Clinical solutions for the clinical trials industr...rst quarter of 2008., For the three months ended ...% to $2,088,000 and the Company reported a net los...basic and diluted basis. These,results compared wi...
(Date:5/8/2008)...search Alliance, an,organization comprised of 12 o...illion Americans to exercise their power over canc...Mother,s Day through Father,s Day., The campaign,...y goals:,to activate Americans everywhere to take ...o exercise their collective power over cancer, and...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Stem cells from hair follicles may help grow new blood vessels 15431 1Stem cells from hair follicles may help grow new blood vessels 15431 2Governor Rendell Writes to Physicians to Explain MCare Fund Assessment Deadline 15429 1Governor Rendell Writes to Physicians to Explain MCare Fund Assessment Deadline 15429 2MITOCHONDRIAL DYSFUNCTION VACCINES AND AUTISM 3A 1 in 50 Children Could Be at Risk 15427 1MITOCHONDRIAL DYSFUNCTION VACCINES AND AUTISM 3A 1 in 50 Children Could Be at Risk 15427 2Hauptman Woodward Appoints Dr Eaton Lattman CEO and Executive Director 15425 1Hauptman Woodward Appoints Dr Eaton Lattman CEO and Executive Director 15425 2Hauptman Woodward Appoints Dr Eaton Lattman CEO and Executive Director 15425 3
... News: Percentage of Working Age People with Diabe...Both PA and National Averages, PITTSBURGH, April 0...usiness Group on Health (PBGH) announced today the...and quality of,care for people with Type 2 diabete... for 2006 presents an overview of patient,demograp...
...y Published in Vaccine Shows Strong Immune Respons...ILLE, Md., April 02, 2007 /PRNewswire-FirstCall/ -...e triggered a robust immune,response and provided ...nza, according to pre- clinical data published in ...ax,s vaccine was tested in three animal models, in...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 2Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 3Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 4
The knee is the body's largest and most complicated joint. Repetitive or inappropriate stresses caused by sports or work often lead to excessive strain. Zeuba Vital Knee Support reinforces the knee j
SofTec Genu is the first functional brace that provides full soft tissue control, enhances natural muscle movement, prevents atrophy, increases proprioception and controls A/P laxity.
Comprifix Knee is a comfortable, lightweight, anatomically knitted knee support with an incorporated donut shaped insert for the reduction of pain and swelling.
McDavid® Patella Knee Support helps relieve the symptoms of chondromalacia patellar subluxation and patellar tendonitis. Features two medial and two lateral spring-steel stays. 3/16" thick neopre
Medicine Products: